Send to

Choose Destination
Curr Oral Health Rep. 2016 Jun;3(2):74-81. Epub 2016 Mar 12.

Immunotherapy for Head and Neck Squamous Cell Carcinoma.

Author information

University of Michigan, 1500 East Medical Center Drive - SPC 5312, Ann Arbor, MI 48109.


Head and neck squamous cell carcinoma has been found to be an immunosuppressive malignancy, with many defects in the host immune system contributing to the progression of disease. A greater understanding of these defects has lead to the identification and investigation of new therapeutic strategies, targeting immune system dysfunction in an effort to improve the outcomes of this disease. This article provides a brief review of the knowledge regarding the immune defects present in head and neck cancer, as well as a review of the current therapeutic strategies being investigated for use.


head and neck cancer; immunology; squamous cell carcinoma

Supplemental Content

Full text links

Icon for PubMed Central
Loading ...
Support Center